BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9449216)

  • 21. Placental Aromatase Is Deficient in Placental Ischemia and Preeclampsia.
    Perez-Sepulveda A; Monteiro LJ; Dobierzewska A; España-Perrot PP; Venegas-Araneda P; Guzmán-Rojas AM; González MI; Palominos-Rivera M; Irarrazabal CE; Figueroa-Diesel H; Varas-Godoy M; Illanes SE
    PLoS One; 2015; 10(10):e0139682. PubMed ID: 26444006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regulation of ovine placental steroid 17 alpha-hydroxylase and aromatase by glucocorticoid.
    France JT; Magness RR; Murry BA; Rosenfeld CR; Mason JI
    Mol Endocrinol; 1988 Mar; 2(3):193-9. PubMed ID: 3135486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Competitive product inhibition of aromatase by natural estrogens.
    Shimizu Y; Yarborough C; Osawa Y
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):651-6. PubMed ID: 8476777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of aromatase and NADPH cytochrome c reductase activities in human endometrium by the human placental NADPH cytochrome c reductase antiserum.
    Tseng L; Bellino FL
    J Steroid Biochem; 1985 Apr; 22(4):555-7. PubMed ID: 3923269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovine placental aromatase: studies of activity levels, kinetic characteristics and effects of aromatase inhibitors.
    France JT; Mason JI; Magness RR; Murry BA; Rosenfeld CR
    J Steroid Biochem; 1987 Aug; 28(2):155-60. PubMed ID: 3626552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen synthetase. Demonstration that the high molecular weight form of NADPH-cytochrome C reductase from human placental microsomes is required for androgen aromatization.
    Bellino FL
    J Steroid Biochem; 1982 Sep; 17(3):261-70. PubMed ID: 6813599
    [No Abstract]   [Full Text] [Related]  

  • 27. Effector role of cytochrome P450 reductase for androstenedione binding to human aromatase.
    Zhang C; Catucci G; Di Nardo G; Gilardi G
    Int J Biol Macromol; 2020 Dec; 164():510-517. PubMed ID: 32698066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase.
    Numazawa M; Mutsumi A; Hoshi K; Tanaka Y
    Biochem Biophys Res Commun; 1992 Jul; 186(1):32-9. PubMed ID: 1632774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-1 stimulates the aromatase activity of human placental cytotrophoblasts.
    Nestler JE
    Endocrinology; 1993 Feb; 132(2):566-70. PubMed ID: 8425476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competitive inhibition and suicide inactivation of human placental aromatase by androst-4-ene-3,6-dione derivatives and 3 alpha-methoxyandrost-4-ene-6,17-dione.
    Numazawa M; Mutsumi A; Kigawa H
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3076-80. PubMed ID: 2085891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoaffinity purification of aromatase cytochrome P-450 from human placental microsomes, metabolic switching from aromatization to 1 beta and 2 beta-monohydroxylation, and recognition of aromatase isozymes.
    Osawa Y; Yoshida N; Fronckowiak M; Kitawaki J
    Steroids; 1987; 50(1-3):11-28. PubMed ID: 3142109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in testosterone metabolism associated with the evolution of placental and gonadal isozymes of porcine aromatase cytochrome P450.
    Corbin CJ; Trant JM; Walters KW; Conley AJ
    Endocrinology; 1999 Nov; 140(11):5202-10. PubMed ID: 10537150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aromatase reaction of 3-deoxyandrogens: steric mode of the C-19 oxygenation and cleavage of the C10-C19 bond by human placental aromatase.
    Numazawa M; Nagaoka M; Sohtome N
    Biochemistry; 2005 Aug; 44(32):10839-45. PubMed ID: 16086586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple functions of aromatase and the active site structure; aromatase is the placental estrogen 2-hydroxylase.
    Osawa Y; Higashiyama T; Shimizu Y; Yarborough C
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):469-80. PubMed ID: 8476762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The constitutive 7-ethoxycoumarin 0-deethylase of human placental microsomes: relationship to the intermediary steps in steroid aromatization.
    Meigs RA
    Life Sci; 1990; 46(5):321-7. PubMed ID: 2304374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of human cytochrome P450 aromatase activity by butyltins.
    Heidrich DD; Steckelbroeck S; Klingmuller D
    Steroids; 2001 Oct; 66(10):763-9. PubMed ID: 11522339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of androgens in human benign prostatic hyperplasia: aromatase and its inhibition.
    Bartsch W; Klein H; Stürenburg HJ; Voigt KD
    J Steroid Biochem; 1987; 27(1-3):557-64. PubMed ID: 2447391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gas chromatography-mass spectrometric determination of activity of human placental aromatase using 16alpha-hydroxyandrostenedione as a substrate.
    Numazawa M; Yoshimura A; Nagaoka M
    Biol Pharm Bull; 2001 May; 24(5):564-6. PubMed ID: 11379781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 19-oxygenated derivatives of androst-4-ene-6,17-dione and androst-5-ene-4,17-dione as catalytic probes for the active site of aromatase.
    Numazawa M; Yamada K; Kidokoro K
    Biol Pharm Bull; 1999 Oct; 22(10):1134-6. PubMed ID: 10549872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of 19-methyl-substituted steroids by human placental aromatase.
    Beusen DD; Carrell HL; Covey DF
    Biochemistry; 1987 Dec; 26(24):7833-41. PubMed ID: 3427108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.